Published in Health Soc Care Community on November 01, 2001
Clinical guidelines: ways ahead. J Eval Clin Pract (1998) 4.56
Data protection legislation: interpretation and barriers to research. BMJ (2000) 4.43
The Iranian health insurance system; past experiences, present challenges and future strategies. Iran J Public Health (2012) 3.28
Same information, different decisions: the influence of evidence on the management of hypertension in the elderly. Br J Gen Pract (1996) 3.15
Alterations in prescribing by general practitioner fundholders: an observational study. BMJ (1995) 2.96
Why do GPs not implement evidence-based guidelines? A descriptive study. Fam Pract (2001) 2.94
The risk of cardiovascular disease in hypertensive patients. Br J Gen Pract (1997) 2.11
Involving consumers in a needs-led research programme: a pilot project. Health Expect (2001) 2.10
Therapeutic conservatism. J R Coll Physicians Lond (1993) 2.02
Pharmacoeconomics: evaluating the evaluators. Br J Clin Pharmacol (1997) 1.89
Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review. QJM (2003) 1.55
Lifestyle medicines. BMJ (2000) 1.50
Economic evaluation under managed competition: evidence from the U.K. Soc Sci Med (1997) 1.48
Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. Health Technol Assess (2003) 1.46
Clinical guidelines: development, implementation, and effectiveness. Postgrad Med J (1995) 1.43
A randomized trial of Evidence-based OutReach (EBOR): rationale and design. Control Clin Trials (1999) 1.42
Review of therapeutically equivalent alternatives to short acting beta(2) adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers. Thorax (1999) 1.42
The impact of health economics on healthcare delivery: the health economists' perspective. Pharmacoeconomics (2001) 1.39
Cost implications of prehospital emergency drug administration. The case of prehospital thrombolytics. Pharmacoeconomics (1996) 1.39
Therapeutic conservatism. J R Coll Physicians Lond (1993) 1.39
The management of hypertension in the elderly by general practitioners in Merseyside: the rule of halves revisited. Br J Gen Pract (1998) 1.39
Health care financing in iran; is privatization a good solution? Iran J Public Health (2012) 1.38
Influences of practice characteristics on prescribing in fundholding and non-fundholding general practices: an observational study. BMJ (1996) 1.37
Prescribing costs in general practice fundholding. Lancet (1996) 1.27
Generic prescribing: time to regulate the market? Price rises are a blow to nascent primary care groups. BMJ (2000) 1.26
Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. Health Technol Assess (2004) 1.26
Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. Health Technol Assess (2007) 1.19
Coronary artery stents: a rapid systematic review and economic evaluation. Health Technol Assess (2004) 1.18
The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature. Health Econ (2001) 1.16
Comparison and reproducibility of transthoracic bioimpedance and dual beam Doppler ultrasound measurement of cardiac function in healthy volunteers. Br J Clin Pharmacol (1991) 1.14
Therapeutic substitution and therapeutic conservatism as cost-containment strategies in primary care: a study of fundholders and non-fundholders. Br J Gen Pract (1999) 1.13
Drug-eluting stents: a systematic review and economic evaluation. Health Technol Assess (2007) 1.10
Addressing barriers to change: an RCT of practice-based education to improve the management of hypertension in the elderly. Br J Gen Pract (1999) 1.10
Clinical guidelines-the hidden costs. BMJ (1999) 1.09
The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review. Health Technol Assess (2011) 1.08
Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses. Pharmacogenomics J (2010) 1.07
Cost effectiveness of drug eluting coronary artery stenting in a UK setting: cost-utility study. Heart (2005) 1.06
The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess (2008) 1.06
The UK indicative prescribing scheme: background and operation. Pharmacoeconomics (1992) 1.03
Lack of an interaction between propranolol and sumatriptan. Br J Clin Pharmacol (1991) 1.02
Pharmacoeconomics: integrating economic evaluation into clinical trials. Br J Clin Pharmacol (1997) 0.99
Supply and regulation of medicines. BMJ (2005) 0.94
FHSA medical advisers: friends or foes? BMJ (1992) 0.94
The management of Pneumocystis carinii pneumonia. Br J Clin Pharmacol (1999) 0.93
Medication errors in primary care in Riyadh City, Saudi Arabia. East Mediterr Health J (2011) 0.93
Medicines regulation and health technology assessment. Clin Pharmacol Ther (2010) 0.92
Risk sharing and payment by results. Clin Pharmacol Ther (2008) 0.92
Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation. Health Technol Assess (2009) 0.91
Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes. Cochrane Database Syst Rev (2005) 0.88
Integrating clinical pharmacology in a new problem based medical undergraduate curriculum. Br J Clin Pharmacol (1997) 0.88
Accounting for noncompliance in pharmacoeconomic evaluations. Pharmacoeconomics (2001) 0.88
Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies. Health Technol Assess (2006) 0.88
Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels. Diabetologia (2006) 0.88
Reporting of adverse drug reactions: practice in the UK. Nurs Times (1998) 0.87
Determinants of physicians' medication prescribing behaviour in primary care in Riyadh City, Saudi Arabia. East Mediterr Health J (2011) 0.85
Physicians medication prescribing in primary care in Riyadh City, Saudi Arabia. Literature review, part 1: variations in drug prescribing. East Mediterr Health J (2011) 0.85
Selective serotonin reuptake inhibitors. BMJ (1992) 0.85
A UK national prescribing list? Pharmacoeconomics (1995) 0.83
Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma. Cochrane Database Syst Rev (2007) 0.83
Local clinical guidelines: description and evaluation of a participative method for their development and implementation. Fam Pract (1996) 0.83
Prescribing at the interface between primary and secondary care in the UK. Towards joint formularies? Pharmacoeconomics (1999) 0.83
Prescription charges: change overdue? Britain can learn from systems of copayments based on drugs' effectiveness. BMJ (1998) 0.82
Economic evaluations during early (phase II) drug development: a role for clinical trial simulations? Pharmacoeconomics (2001) 0.82
Hypertension in the elderly: attitudes of British patients and general practitioners. J Hum Hypertens (1998) 0.82
Early access to new medicines. Clin Pharmacol Ther (2008) 0.81
Review article: current treatment and optimal patient management in pancreatic cancer. Aliment Pharmacol Ther (1998) 0.81
Interaction of metoprolol and fluoxetine. Lancet (1993) 0.81
Auditing the management of hypertension in British general practice: a critical literature review. Br J Gen Pract (1998) 0.81
Erlotinib for the treatment of relapsed non-small cell lung cancer. Health Technol Assess (2009) 0.80
The association of some practice characteristics with antibiotic prescribing. Pharmacoepidemiol Drug Saf (1999) 0.80
Predictors of quality of medication prescribing in primary care in Riyadh City, Saudi Arabia. East Mediterr Health J (2011) 0.80
The influence of practice characteristics on the prescribing of benzodiazepines and appetite suppressant drugs. Pharmacoepidemiol Drug Saf (1998) 0.79
Loperamide related toxic megacolon in Clostridium difficile colitis. Postgrad Med J (1990) 0.79
The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation. Health Technol Assess (2010) 0.79
Haemodynamic responses in young and elderly, healthy subjects during ambient and warm head-up tilt. Clin Sci (Lond) (1998) 0.78
Physicians' medication prescribing in primary care in Riyadh City, Saudi Arabia. Literature review, part 2: rational prescribing. East Mediterr Health J (2011) 0.78
Physicians' medication prescribing in primary care . in Riyadh City, Saudi Arabia. Literature review, part 3: prescribing errors. East Mediterr Health J (2011) 0.78
[Medication prescribing pattern in primary care in Riyadh City, Saudi Arabia] East Mediterr Health J (2011) 0.78
Development of an economic model for the management of upper gastrointestinal disease in primary care. Preliminary findings. Pharmacoeconomics (1998) 0.77
Comparing hypertension guidelines. Technical difficulties may have affected study's results. BMJ (1996) 0.77
Benefit of statins in daily practice? A six-year retrospective observational study. Pharmacol Res (2009) 0.77
Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation. Health Technol Assess (2007) 0.77
Effectiveness of three interventions on primary care physicians' medication prescribing in Riyadh City, Saudi Arabia. East Mediterr Health J (2011) 0.77
Review article: current practice and future perspectives in detection and diagnosis of pancreatic cancer. Aliment Pharmacol Ther (1998) 0.76
Availability of medicines in the European Union: results from the EURO-Medicines project. Eur J Clin Pharmacol (2001) 0.76
Topical NSAIDs are better than placebo. Safety, efficacy, and therapeutic role of nsaids must be clarified. BMJ (1998) 0.75
Generic substitution. J R Coll Physicians Lond (1993) 0.75
"Slurry lung": a report of three cases. Thorax (1991) 0.75
Impedance cardiography. Br J Clin Pharmacol (1993) 0.75
ACE inhibitors and peripheral vascular disease. Lancet (1990) 0.75
The future of health research in the UK. Lancet (2006) 0.75
Feasibility study of multicentre comparison of NHS hospital pharmacy computer data. Br J Clin Pharmacol (2000) 0.75
Upper gastrointestinal endoscopy. BMJ (1995) 0.75
Cost effectiveness of lowering cholesterol. Study did not take account of confounders. BMJ (1996) 0.75
Effects of fundholding on prescribing habits. Results of similar study in Mersey were different. BMJ (1996) 0.75
Therapeutic conservatism. J R Coll Physicians Lond (1994) 0.75
How evidence is reviewed. Occas Pap R Coll Gen Pract (2001) 0.75
Metipranolol-induced adverse reactions: I. The rechallenge study. Eye (Lond) (1992) 0.75
Importance of health economics must be recognised when trials are designed. BMJ (1999) 0.75